ArticleAutoimmunity reviews2020
Imatinib might constitute a treatment option for lung involvement in COVID-19.
Article in Autoimmunity reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- Imatinib decreases germ cell survival and germline stem cell proliferation in rodent testis ex vivo and in vitro.Andrology · 2025Article
- Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.Pharmaceuticals (Basel, Switzerland) · 2023Review
- In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19.Chemicke zvesti · 2023Article
- Review
- COVID-19, cytokines, inflammation, and spices: How are they related?Life sciences · 2021Review
- Review of pharmacologic and immunologic agents in the management of COVID-19.Biosafety and health · 2021Review
- COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.Cancer · 2021Article
- COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.Frontiers in medicine · 2021Review
- Commonalities Between COVID-19 and Radiation Injury.Radiation research · 2021Review
- Drug-Induced Liver Disturbance During the Treatment of COVID-19.Frontiers in pharmacology · 2021Review
- COVID-19 therapy: What weapons do we bring into battle?Bioorganic & medicinal chemistry · 2020Article
- Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020Article
- Imatinib for COVID-19: A case report.Clinical immunology (Orlando, Fla.) · 2020Article
- Impact of Imatinib on reducing the painful crisis in patients with sickle cell disease.Hematology, transfusion and cell therapyArticle
Corrections and comments
- Comment on
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.